BioCorRx Inc. (BICX)
OTCMKTS · Delayed Price · Currency is USD
0.2010
-0.0490 (-19.60%)
Aug 27, 2026, 4:00 PM EST
BioCorRx Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.65 | 0.8 | 0.01 | 0.09 | 0.21 | 0.05 | |
Revenue Growth | 107.94% | 10301.10% | -91.40% | -58.30% | 342.99% | -60.63% |
Cost of Revenue | 0.19 | 0.02 | 0 | 0.04 | 0.02 | 0.01 |
Gross Profit | 0.46 | 0.78 | 0.01 | 0.05 | 0.2 | 0.04 |
Selling, General & Admin | 3.16 | 3.79 | 3.61 | 2.88 | 3.41 | 3.74 |
Research & Development | 2.37 | 1.77 | 1.48 | 0.89 | 1.46 | 1.61 |
Operating Expenses | 5.51 | 5.61 | 5.13 | 3.79 | 4.9 | 5.41 |
Operating Income | -5.05 | -4.83 | -5.12 | -3.74 | -4.7 | -5.37 |
Interest Expense | -0.75 | -0.86 | -1.53 | -0.89 | -1.09 | -0.57 |
Other Non Operating Income (Expenses) | 2.66 | 2.37 | 1.6 | 0.94 | 1.79 | 0.87 |
EBT Excluding Unusual Items | -3.14 | -3.32 | -5.05 | -3.69 | -4 | -5.07 |
Asset Writedown | -0.01 | - | - | -0.05 | - | -0.14 |
Legal Settlements | - | - | - | - | -0.32 | - |
Other Unusual Items | -0.15 | -0.19 | -0.16 | -0.03 | -0.06 | - |
Pretax Income | -3.29 | -3.51 | -5.21 | -3.77 | -4.38 | -5.21 |
Earnings From Continuing Operations | -3.29 | -3.51 | -5.21 | -3.77 | -4.38 | -5.21 |
Minority Interest in Earnings | 0.02 | 0.07 | 0.11 | 0 | 0.01 | 0 |
Net Income | -3.28 | -3.44 | -5.11 | -3.77 | -4.37 | -5.21 |
Preferred Dividends & Other Adjustments | - | - | - | - | - | 0.07 |
Net Income to Common | -3.28 | -3.44 | -5.11 | -3.77 | -4.37 | -5.28 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 24 | 18 | 10 | 8 | 7 | 6 |
Shares Outstanding (Diluted) | 24 | 18 | 10 | 8 | 7 | 6 |
Shares Change | 73.37% | 76.66% | 25.41% | 15.92% | 10.90% | 20.70% |
EPS (Basic) | -0.14 | -0.19 | -0.49 | -0.45 | -0.61 | -0.81 |
EPS (Diluted) | -0.14 | -0.19 | -0.49 | -0.45 | -0.61 | -0.81 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.36 | -2.3 | -1.1 | -1.85 | -2.04 | -3.54 |
Free Cash Flow Per Share | -0.10 | -0.12 | -0.10 | -0.22 | -0.28 | -0.55 |
Gross Margin | 70.52% | 97.27% | 78.25% | 59.64% | 92.86% | 87.82% |
Operating Margin | -774.96% | -606.04% | -66829.81% | -4194.50% | -2196.96% | -11121.62% |
Profit Margin | -503.10% | -431.51% | -66616.10% | -4224.89% | -2043.30% | -10934.66% |
Free Cash Flow Margin | -361.74% | -288.28% | -14302.07% | -2078.60% | -954.81% | -7332.77% |
EBITDA | -5.08 | -4.79 | -5.09 | -3.71 | -4.67 | -5.3 |
D&A For EBITDA | -0.03 | 0.04 | 0.03 | 0.03 | 0.03 | 0.06 |
EBIT | -5.05 | -4.83 | -5.12 | -3.74 | -4.7 | -5.37 |
Advertising Expenses | - | 0.07 | 0.03 | 0.11 | 0.33 | 0.43 |